ADA 2018: SGLT2 Inhibitors in the Management of Type 2 Diabetes

ADA 2018: SGLT2 Inhibitors in the Management of Type 2 Diabetes

Chapter 13 Pharmacologic Management of Type 2Подробнее

Chapter 13 Pharmacologic Management of Type 2

Treating Diabetes: Heart Smart BenefitsПодробнее

Treating Diabetes: Heart Smart Benefits

HOT TOPIC: Diabetic Kidney Disease (DKD) – News You Should Know NowПодробнее

HOT TOPIC: Diabetic Kidney Disease (DKD) – News You Should Know Now

Diabetes MedicationsПодробнее

Diabetes Medications

ADA/EASD consensus in management of type 2 diabetes mellitus: what's new? By Dr MELANIE DAVIESПодробнее

ADA/EASD consensus in management of type 2 diabetes mellitus: what's new? By Dr MELANIE DAVIES

Type 2 Diabetes: The Benefits and Cost-Effectiveness of SGLT2 InhibitorsПодробнее

Type 2 Diabetes: The Benefits and Cost-Effectiveness of SGLT2 Inhibitors

The ADA Type 2 Diabetes Management AlgorithmПодробнее

The ADA Type 2 Diabetes Management Algorithm

UP Med Webinars 2019: "Updates on Drug Therapy of Type 2 DM: Out with the Old, In with the New?"Подробнее

UP Med Webinars 2019: 'Updates on Drug Therapy of Type 2 DM: Out with the Old, In with the New?'

Management of hyperglycaemia in type 2 diabetes. 2018 EASD–ADA guidelinesПодробнее

Management of hyperglycaemia in type 2 diabetes. 2018 EASD–ADA guidelines

Why cardiologists must focus on their patients with diabetesПодробнее

Why cardiologists must focus on their patients with diabetes

State of the Art: Diabetes Management with Respect to CVD and CKD in 2018Подробнее

State of the Art: Diabetes Management with Respect to CVD and CKD in 2018

Популярное